1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Adenoviral Vectors 1.2.3 Adeno-associated Viral Vectors 1.2.4 Retroviral Vectors 1.2.5 Lentiviral Vectors 1.2.6 Other 1.3 Market by Application 1.3.1 Global Viral Vector Manufacturing Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Gene Therapy 1.3.3 Vaccinology 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Viral Vector Manufacturing Market Perspective (2017-2028) 2.2 Viral Vector Manufacturing Growth Trends by Region 2.2.1 Viral Vector Manufacturing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Viral Vector Manufacturing Historic Market Size by Region (2017-2022) 2.2.3 Viral Vector Manufacturing Forecasted Market Size by Region (2023-2028) 2.3 Viral Vector Manufacturing Market Dynamics 2.3.1 Viral Vector Manufacturing Industry Trends 2.3.2 Viral Vector Manufacturing Market Drivers 2.3.3 Viral Vector Manufacturing Market Challenges 2.3.4 Viral Vector Manufacturing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Viral Vector Manufacturing Players by Revenue 3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2017-2022) 3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2017-2022) 3.2 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Viral Vector Manufacturing Revenue 3.4 Global Viral Vector Manufacturing Market Concentration Ratio 3.4.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2021 3.5 Viral Vector Manufacturing Key Players Head office and Area Served 3.6 Key Players Viral Vector Manufacturing Product Solution and Service 3.7 Date of Enter into Viral Vector Manufacturing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Viral Vector Manufacturing Breakdown Data by Type 4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2017-2022) 4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2023-2028) 5 Viral Vector Manufacturing Breakdown Data by Application 5.1 Global Viral Vector Manufacturing Historic Market Size by Application (2017-2022) 5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Viral Vector Manufacturing Market Size (2017-2028) 6.2 North America Viral Vector Manufacturing Market Size by Country (2017-2022) 6.3 North America Viral Vector Manufacturing Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Viral Vector Manufacturing Market Size (2017-2028) 7.2 Europe Viral Vector Manufacturing Market Size by Country (2017-2022) 7.3 Europe Viral Vector Manufacturing Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Viral Vector Manufacturing Market Size (2017-2028) 8.2 Asia-Pacific Viral Vector Manufacturing Market Size by Country (2017-2022) 8.3 Asia-Pacific Viral Vector Manufacturing Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Viral Vector Manufacturing Market Size (2017-2028) 9.2 Latin America Viral Vector Manufacturing Market Size by Country (2017-2022) 9.3 Latin America Viral Vector Manufacturing Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Viral Vector Manufacturing Market Size (2017-2028) 10.2 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2017-2022) 10.3 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 BioReliance 11.1.1 BioReliance Company Detail 11.1.2 BioReliance Business Overview 11.1.3 BioReliance Viral Vector Manufacturing Introduction 11.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2017-2022) 11.1.5 BioReliance Recent Development 11.2 Cobra Biologics 11.2.1 Cobra Biologics Company Detail 11.2.2 Cobra Biologics Business Overview 11.2.3 Cobra Biologics Viral Vector Manufacturing Introduction 11.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2017-2022) 11.2.5 Cobra Biologics Recent Development 11.3 Oxford BioMedica 11.3.1 Oxford BioMedica Company Detail 11.3.2 Oxford BioMedica Business Overview 11.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction 11.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2017-2022) 11.3.5 Oxford BioMedica Recent Development 11.4 UniQure 11.4.1 UniQure Company Detail 11.4.2 UniQure Business Overview 11.4.3 UniQure Viral Vector Manufacturing Introduction 11.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2017-2022) 11.4.5 UniQure Recent Development 11.5 FinVector 11.5.1 FinVector Company Detail 11.5.2 FinVector Business Overview 11.5.3 FinVector Viral Vector Manufacturing Introduction 11.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2017-2022) 11.5.5 FinVector Recent Development 11.6 MolMed 11.6.1 MolMed Company Detail 11.6.2 MolMed Business Overview 11.6.3 MolMed Viral Vector Manufacturing Introduction 11.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2017-2022) 11.6.5 MolMed Recent Development 11.7 MassBiologics 11.7.1 MassBiologics Company Detail 11.7.2 MassBiologics Business Overview 11.7.3 MassBiologics Viral Vector Manufacturing Introduction 11.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2017-2022) 11.7.5 MassBiologics Recent Development 11.8 FUJIFILM Diosynth Biotechnologies 11.8.1 FUJIFILM Diosynth Biotechnologies Company Detail 11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview 11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction 11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2017-2022) 11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development 11.9 Lonza 11.9.1 Lonza Company Detail 11.9.2 Lonza Business Overview 11.9.3 Lonza Viral Vector Manufacturing Introduction 11.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2017-2022) 11.9.5 Lonza Recent Development 11.10 Biovian 11.10.1 Biovian Company Detail 11.10.2 Biovian Business Overview 11.10.3 Biovian Viral Vector Manufacturing Introduction 11.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2017-2022) 11.10.5 Biovian Recent Development 11.11 Thermo Fisher Scientific (Brammer Bio) 11.11.1 Thermo Fisher Scientific (Brammer Bio) Company Detail 11.11.2 Thermo Fisher Scientific (Brammer Bio) Business Overview 11.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Introduction 11.11.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2017-2022) 11.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Adenoviral Vectors Table 3. Key Players of Adeno-associated Viral Vectors Table 4. Key Players of Retroviral Vectors Table 5. Key Players of Lentiviral Vectors Table 6. Key Players of Other Table 7. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Viral Vector Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Viral Vector Manufacturing Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Viral Vector Manufacturing Market Share by Region (2017-2022) Table 11. Global Viral Vector Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Viral Vector Manufacturing Market Share by Region (2023-2028) Table 13. Viral Vector Manufacturing Market Trends Table 14. Viral Vector Manufacturing Market Drivers Table 15. Viral Vector Manufacturing Market Challenges Table 16. Viral Vector Manufacturing Market Restraints Table 17. Global Viral Vector Manufacturing Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Viral Vector Manufacturing Market Share by Players (2017-2022) Table 19. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2021) Table 20. Ranking of Global Top Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Viral Vector Manufacturing Product Solution and Service Table 24. Date of Enter into Viral Vector Manufacturing Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Viral Vector Manufacturing Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Viral Vector Manufacturing Revenue Market Share by Type (2017-2022) Table 28. Global Viral Vector Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Viral Vector Manufacturing Revenue Market Share by Type (2023-2028) Table 30. Global Viral Vector Manufacturing Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Viral Vector Manufacturing Revenue Market Share by Application (2017-2022) Table 32. Global Viral Vector Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Viral Vector Manufacturing Revenue Market Share by Application (2023-2028) Table 34. North America Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 44. BioReliance Company Detail Table 45. BioReliance Business Overview Table 46. BioReliance Viral Vector Manufacturing Product Table 47. BioReliance Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 48. BioReliance Recent Development Table 49. Cobra Biologics Company Detail Table 50. Cobra Biologics Business Overview Table 51. Cobra Biologics Viral Vector Manufacturing Product Table 52. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 53. Cobra Biologics Recent Development Table 54. Oxford BioMedica Company Detail Table 55. Oxford BioMedica Business Overview Table 56. Oxford BioMedica Viral Vector Manufacturing Product Table 57. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 58. Oxford BioMedica Recent Development Table 59. UniQure Company Detail Table 60. UniQure Business Overview Table 61. UniQure Viral Vector Manufacturing Product Table 62. UniQure Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 63. UniQure Recent Development Table 64. FinVector Company Detail Table 65. FinVector Business Overview Table 66. FinVector Viral Vector Manufacturing Product Table 67. FinVector Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 68. FinVector Recent Development Table 69. MolMed Company Detail Table 70. MolMed Business Overview Table 71. MolMed Viral Vector Manufacturing Product Table 72. MolMed Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 73. MolMed Recent Development Table 74. MassBiologics Company Detail Table 75. MassBiologics Business Overview Table 76. MassBiologics Viral Vector Manufacturing Product Table 77. MassBiologics Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 78. MassBiologics Recent Development Table 79. FUJIFILM Diosynth Biotechnologies Company Detail Table 80. FUJIFILM Diosynth Biotechnologies Business Overview Table 81. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Product Table 82. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 83. FUJIFILM Diosynth Biotechnologies Recent Development Table 84. Lonza Company Detail Table 85. Lonza Business Overview Table 86. Lonza Viral Vector Manufacturing Product Table 87. Lonza Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 88. Lonza Recent Development Table 89. Biovian Company Detail Table 90. Biovian Business Overview Table 91. Biovian Viral Vector Manufacturing Product Table 92. Biovian Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 93. Biovian Recent Development Table 94. Thermo Fisher Scientific (Brammer Bio) Company Detail Table 95. Thermo Fisher Scientific (Brammer Bio) Business Overview Table 96. Thermo Fisher Scientific (Brammer Bio) Viral Vector ManufacturingProduct Table 97. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million) Table 98. Thermo Fisher Scientific (Brammer Bio) Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global Viral Vector Manufacturing Market Share by Type: 2021 VS 2028 Figure 2. Adenoviral Vectors Features Figure 3. Adeno-associated Viral Vectors Features Figure 4. Retroviral Vectors Features Figure 5. Lentiviral Vectors Features Figure 6. Other Features Figure 7. Global Viral Vector Manufacturing Market Share by Application in 2021 & 2028 Figure 8. Gene Therapy Case Studies Figure 9. Vaccinology Case Studies Figure 10. Viral Vector Manufacturing Report Years Considered Figure 11. Global Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Viral Vector Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Viral Vector Manufacturing Market Share by Region: 2021 VS 2028 Figure 14. Global Viral Vector Manufacturing Market Share by Players in 2021 Figure 15. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2021 Figure 17. North America Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Viral Vector Manufacturing Market Share by Country (2017-2028) Figure 19. United States Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Viral Vector Manufacturing Market Share by Country (2017-2028) Figure 23. Germany Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2017-2028) Figure 31. China Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Viral Vector Manufacturing Market Share by Country (2017-2028) Figure 39. Mexico Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Viral Vector Manufacturing Market Share by Country (2017-2028) Figure 43. Turkey Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. BioReliance Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 46. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 47. Oxford BioMedica Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 48. UniQure Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 49. FinVector Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 50. MolMed Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 51. MassBiologics Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 52. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 53. Lonza Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 54. Biovian Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 55. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics FUJIFILM Diosynth Biotechnologies Lonza Biovian Thermo Fisher Scientific (Brammer Bio)